Brian Goff

CIK 1546216 · Chief Executive Officer · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.63M

Companies

3

Total Filings

40

Lifetime Open-Market Net

-$5.41M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NTLA Director 32,609 $12.11 $394.9K $0 3 2026-06-10
AGIO Chief Executive Officer 177,604 $29.46 $5.23M -$5.41M 15 2026-04-06
Baxalta Inc (BXLT) Delisted EVP and President, Hematology 67,030 $0 5 2016-03-08

Recent Filings · Page 2 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-07 AGIO Mixed +13,412 -$591.7K EDGAR
2024-03-05 AGIO Mixed +4,344 -$135.4K EDGAR
2024-01-24 AGIO Mixed +9,383 -$165.2K EDGAR
2024-01-09 AGIO Mixed +13,461 -$277.4K EDGAR
2023-08-10 AGIO Mixed +12,513 -$259.3K EDGAR
2023-06-30 AGIO Mixed +14,079 -$324.7K EDGAR
2023-03-03 AGIO Grant (A) $0 EDGAR
2022-08-09 AGIO Grant (A) $0 EDGAR
2021-07-23 Disp (D) −150,832 $0
2021-07-16 Grant (A) +60,144 $0
Showing 1120 of 40
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.